The effect of gonadotropin-releasing hormone agonist on thyroid-stimulating hormone and prolactin secretion in adult premenopausal women
|
|
- Griselda Simpson
- 6 years ago
- Views:
Transcription
1 FERTILITY AND STERILITY Vol. 64, No.4, October 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. The effect of gonadotropin-releasing hormone agonist on thyroid-stimulating hormone and prolactin secretion in adult premenopausal women Samuel J. Chantilis, M.D. * Cathy Barnett-Hamm, R.N.C. William E. Byrd, Ph.D. Bruce R. Carr, M.D. Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, The University of Texas Southwestern Medical Center, Dallas, Texas Objective: To investigate the effects of chronic administration of GnRH agonists (GnRH-a) on pituitary TSH and PRL secretion in adult women. Design: Prospective case-controlled study. Setting: Academic division of Reproductive Endocrinology, Department of Obstetrics and Gynecology. Patients: Ten ovulatory women and 10 women treated with monthly depot injections of leuprolide acetate (3.75 mg) were studied. Interventions: All subjects underwent pituitary stimulation with human thyrotropin-releasing hormone (TRH), 500 j-lg IV. Main Outcome Measures: Basal and post-trh-stimulated serum levels of TSH and PRL at 15, 30, 45, 60, 90, 120, and 180 minutes were compared among the two groups. Also, basal oft4, triiodothyronine, and triiodothyronine resin uptake studies were obtained and compared among the GnRH-a-treated and control groups. Results: No statistically significant difference between baseline or TRH-stimulated serum TSH and PRL could be detected between control and GnRH-a-treated groups of women. Furthermore, these groups were similar with respect to routine thyroid function assays. Conclusion: Gonadotropin-releasing hormone agonist does not significantly affect baseline or TRH-stimulated TSH and PRL levels nor basal serum T4 and triiodothyronine levels or triiodothyronine resin uptake in adult women. Fertil SterilI995;64: Key Words: Gonadotropin-releasing hormone agonist, thyroid-stimulating hormone, prolactin, pituitary Gonadotropin-releasing hormone agonists (GnRH -a) have been used extensively for the treatment of a variety of endocrine-related disorders due to the suppressive effects on serum FSH, LH, and subsequently gonadal sex steroids, that is, E2 and T. The use of these agents to treat uterine leiomyomata, endometriosis, and premenstrual syndrome in adult women via suppression of gonadal steroid production is well documented (1). Gonadotropin-releasing Received January 31,1995; revised and accepted May 23,1995. * Reprint requests: Samuel J. Chantilis, M.D., Department of Obstetrics and Gynecology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas (FAX: ). hormone agonists are also used to delay the effects of the premature awakening of the hypothalamicpituitary-gonadal axis in children with precocious puberty by inhibition of gonadotropin suppression (2). Gonadotropin-releasing hormone agonists may affect aspects of pituitary function other than gonadotropins, that is, GH and PRL secretion. Our group (3) previously demonstrated a reduction in GH-releasing hormone (RH)-stimulated release of GH in women, whereas basal GH and insulin-like growth factor levels were not affected. We suggested that the reduction in GH release may be due to decreased E2 levels (3). We hypothesized that thyrotropin-releasing hormone (TRH)-stimulated PRL release 698 Chantilis et al. Effect of GnRH-a on TSH and PRL secretion Fertility and Sterility
2 might also be simultaneously affected. Golan and co-workers (4) suggested that GnRH-a may reduce serum PRL in patients with hyperprolactinemia, although GnRH-a treatment did not lower PRL levels in individuals who were euprolactinemic. Alteration of TSH secretion with chronic administration of GnRH-a, however, has not been reported. The purpose of our study was to investigate what effects GnRH -a administered chronically may have on basal and TRH-stimulated pituitary TSH and PRL secretion in adult women. Dynamic testing with TRH was performed to assess pituitary TSH and PRL secretion in the event that GnRH-a may affect stimulated, but not basal, serum levels of these hormones. Basal thyroid function studies from GnRH-a-treated women are also reported. MATERIALS AND METHODS Ten ovulatory women (group 1) served as control subjects and were recruited from the medical school and community at large. Ten GnRH-a-treated women (group 2) who had received at least two (but <4) monthly depot injections of depot leuprolide acetate (LA, 3.75 mg; TAP Pharmaceuticals, Chicago, IL) were recruited to serve as the experimental subjects. All women were between the ages of 21 and 38 years with a body weight of 47 to 85 kg (100 to 180 lbs). Subjects who had a recent (l-year) history of irregular menses, chronic anovulation, luteal phase defect, or any history of hyperprolactinemia, galactorrhea, thyroid disease, central nervous system disease, or cardiopulmonary disease were excluded from the study. Leuprolide acetate for depot suspension was prescribed for all subjects for the indications of either endometriosis or uterine leiomyomas. All subjects agreed to participate in this study and signed an informed consent approved by the Institutional Review Board of The University of Texas Southwestern Medical Center at Dallas. Human TRH (5-0xY-L-propyl-L-histidyl-L-proline amide) was obtained from Abbott Laboratories-Diagnostic Division (Abbott Park, IL). All subjects were studied beginning at 7:00 to 9:00 A.M. after a 7- to 9-hour fasting state. Control women (group 1) were studied during the follicular phase of their ovarian cycle. Experimental subjects (group 2) had been receiving monthly GnRH-a therapy for a minimum of 6 weeks but for <3 months. Down-regulation of the pituitary gland was confirmed by observation of suppressed baseline E2 levels in all experimental subjects. All subjects were in the sitting position and remained awake during the study. Blood pressure and pulse were recorded every 15 minutes during the 1st hour ofthe study and every 30 minutes thereafter, until the completion of the study. An 18-gauge IV catheter was placed in the subjects' forearms and connected to a heparin lock to maintain patency. Basal blood samples were collected 0.25 hours after catheter placement, which served as the initial time point. TRH (500 f.lg) was administered over 1 minute as a bolus injection. Blood samples were subsequently collected at 15, 30, 45, 90, 120, and 180 minutes after TRH administration. Blood samples for all studies were collected in serum tubes and were immediately centrifuged at 300 X g (2,800 rpm) at 5 C for 10 minutes. Supernatant serum was stored at -20 C until assayed. Assays Estradiol, FSH, LH, TSH, PRL, total and unbound T4 serum levels, triiodothyronine resin uptake, and total and unbound triiodothyronine serum levels were quantified by immunoassays obtained from Diagnostic Products Corporation (Los Angeles, CA). All samples from each subject were analyzed in a single assay. Statistical Analysis Comparison of hormone concentrations between the two groups at baseline and given time periods were analyzed using an unpaired two-tailed Student's t-test. The level of significance was P $ RESULTS Upon completion of the study, the results from 20 subjects were available for analysis with 10 subjects each in the control and study groups. Group 1 consisted of four black and six white women; group 2 consisted ofthree black and seven white women. The means ± SE with respect to age and weight for group 1 (32.1 ± 1.50 years, 68.4 ± 3.27 kg) were similar to group 2 (31.7 ± 2.01 years, 65.8 ± 4.06 kg) (Table 1). The groups were similar with respect to transient side effects experienced by all subjects upon administration of TRH. Side effects included transient nausea (19 subjects), facial flushing (3 subjects), lightheadedness (6 subjects), urgency (4 subjects), headaches (3 subjects), and palpitations or chest pressure (2 subjects). None ofthese side effects were endured longer than 5 minutes, and no significant changes in pulse or blood pressure were detected. The mean basal serum E2 and LH levels were significantly higher (P < 0.05) in group 1 subjects (129.9 pg/ml [conversion factor to SI unit, 3.671] and miu/ml [conversion factor to SI unit, 1.00], respectively) than group 2 subjects (22.1 pgl ml and 0.7 miu/ml, respectively). An LH surge (57 Vol. 64, No.4, October 1995 Chantilis et a1. Effect of GnRH a on TSH and PRL secretion 699
3 Table 1 Comparison of Age, Weight, and Basal Serum Hormone Levels Between Control (Group 1) and GnRH-a-Treated (Group 2) Subjects* Assay Group 1t Age (y) 32.1 :!: 1.50 Weight (kg) 68.4 :!: 3.27 Ez (pg/ml) :!: 86.1 FSH (miu/ml) 5.8 :!: 1.0 LH (miu/ml) :!: 5.3 TSH (miuil) 1.5 :!: 0.7 PRL (ng/ml) 7.7 :!: 2.7 T4, total (flg/dl) 7.0 :!: 0.9 T4, unbound (flg/dl) 1.1 :!: 0.2 Triiodothyronine resin uptake (%) 29 :!: 2 Triiodothyronine, total (ng/dl) :!: 24.9 Triiodothyronine, unbound (ng/dl) 2.6 :!: 0.6 Group 2t 31.7 :!: :!: :!: :!: :!: :!: :!: :!: :!: :!: :!: :!: 1.0 * Both groups contained 10 subjects. t Values are means:!: SEM. :j: Significance level is <0.05;, not significant. Conversion factors to SI units are as follows: E 2, 3.671; FSH, LH, TSH, and PRL, 1.00; total T4 and unbound T4, 12.87; total triiodothyronine and unbound triiodothyronine, II n = 9; one subject in group 1 with an LH surge was excluded. p:j: <0.05 <0.05 miu/ml) was detected in one subject in group 1, but when excluded, the control group mean serum LH (5.6 miu/ml) remained significantly higher (P < 0.05) than that of group 2. The mean basal serum F8H was higher in group 1 (5.8 miu/ml [conversion factor to 81 unit, 1.00]) than group 2 (2.8 miu/ml) but did not reach statistical significance (P = 0.178). The suppressed levels of E2 and gonadotropins in group 2 patients confirm GnRH-a suppression of the hypothalamic-pituitary-ovarian axis. The mean ± 8E basal T8H level in group 1 (1.5 ± 0.7 miu/l [conversion factor to 81 unit, 1.00]) was similar (P = 0.628) to group 2 (1.3 ± 0.7 miu/l). The effects of GnRH-a on T8H secretion in response to TRH stimulation is presented in Figure 1. Mter an IV bolus infusion of TRH (500 p,g), mean ± 8E peak T8H secretion was achieved at 30 minutes, reaching levels of 16.6 ± 1.8 miuil in group 1 and 12.9 ± 2.2 miu/l in group 2. Although GnRH-a appear to suppress T8H secretion, the differences are not statistically significant at any time point assayed. There was no difference (P = 0.367) between the basal serum PRL levels of group 1 (7.7 ± 0.9 ng/ml [conversion factor to 81 unit, 1.00]) and group 2 (6.7 ± 0.7 ng/ml). The effect of GnRH-a on PRL secretion after TRH stimulation is shown in Figure 2. The mean ± 8E peak PRL levels were obtained 30 minutes after TRH administration and were 53.9 ± 16.4 ng/ml in group 1 and 57.5 ± 28.3 ng/ml in group 2. Gonadotropin-releasing hormone agonist administration had no demonstrable effect on PRL secretion after TRH stimulation of the pituitary ~! 10 5 ol l l---'------" o TIME (MINUTES) Figure 1 Effect of GnRH-a on TRH-stimulated TSH release. D, mean::+:: SE serum TSH values for the control women (n = 10); e, mean::+:: SE serum TSH values for the experimental women receiving GnRH-a for a minimum of 6 weeks. Time points are relative to TRH bolus infusion. gland in the subjects in group 2. Prolactin levels from all time points measured were similar between the two groups. The effect of GnRH-a administration on basal thyroid function was evaluated with comparison of thyroid hormone levels and the triiodothyronine resin uptake assay between the groups. There was no significant difference among the two groups with respect to total or unbound free T 4, triiodothyronine ::r, a 80 z i= u... C 0 a: a TIME (MINUTES) Figure 2 Effect of GnRH-a on TRH-stimulated PRL release. D, mean::+:: SE serum PRL values for the control women (n = 10); e, mean::+:: SE serum PRL values for the experimental women receiving GnRH-a for a minimum of 6 weeks. Time points are relative to TRH bolus infusion. 700 Chantilis et al. Effect of GnRH-a on TSH and PRL secretion Fertility and Sterility
4 resin uptake, and total or unbound triiodothyronine (Table 1). DISCUSSION The use of GnRH-a for long-term suppression of gonadal steroid production is widely accepted for the treatment of a wide variety of endocrine-related diseases. These agents may also affect the secretion of pituitary hormones other than gonadotropins and may affect stimulated but not basal values. By way of example, Word and colleagues (3) demonstrated suppression of GH release after stimulation by GH RH in premenopausal women compared with control women, although basal serum levels of neither GH nor insulin-like growth factor-i were affected. In contrast, GnRH-a do not affect basal nor corticotropinreleasing hormone-stimulated ACTH release in adult women (5). The specific mechanism by which GnRH-a may affect nongonadotropin pituitary hormonal secretion is unknown. We found no significant effect on basal or TRHstimulated secretion of TSH, although GnRH-atreated group 2 subjects had a diminished response. Our thyroid function testing of unchanged total or unbound T 4, total or unbound triiodothyronine, and the triiodothyronine resin uptake levels were similar in GnRH-a-treated and control women, which is consistent with our findings of unaltered basal and TRH-stimulated TSH levels. These data are in agreement with those of Cedars and colleagues (6), who found no change in the free thyroxin index in women receiving chronic GnRH-a. We found GnRH-a had no significant effect on TSH secretion, whereas the serum E 2 1evel in group 2 subjects clearly demonstrated suppression of the hypothalamic-pituitarygonadal axis. Based on our previous study of the effects of GnRH-a to suppress GnRH-stimulated GH release, possibly due to lowered estrogen, we hypothesized that TRH-stimulated PRL release might also be suppressed by GnRH-a. This seemed plausible because PRL levels increase in response to estrogen. However, the two study groups were similar with respect to basal and TRH-stimulated PRL levels. Our findings of similar basal PRL levels among the two groups are consistent with those of several investigators who also found no significant differences of basal PRL levels in women exposed to chronic GnRH-a therapy (4, 7, 8). Venturini and colleagues (7) followed 32 adult women diagnosed with endometriosis who were treated for 6 months with GnRH-a goserelin acetate depot and found no significant change in basal serum PRL levels when compared with pretreatment levels. Sklar and co-workers (8) found no difference in unstimulated PRL secretion before and after LA treatment of 11 children with central precocious puberty. Fifteen adult euprolactinemic women with uterine leiomyomata treated with GnRH-a by Golan and colleagues (4) failed to demonstrate a significant change in PRL secretion, although one woman with hyperprolactinemia had significant suppression of serum PRL. None of these investigators (4,7,8), however, evaluated stimulated PRL levels, viz., all of these studies compared basal, that is, unstimulated pretreatment to post-treatment, levels of PRL. Other investigators (9, 10) reported chronic GnRH-a treatment results in diminished serum PRL levels (unstimulated), but these results may be secondary to the markedly higher E2 levels in the control groups as estrogens are believed to augment PRL secretion in women (11, 12). In summary, we analyzed the effect of GnRH-a on the secretion of TSH and PRL before and after IV infusion of TRH. We found no alteration in the basal or stimulated patterns of TSH and PRL secretion in reproductive-aged women treated chronically with GnRH-a. Additionally, we performed common thyroid function tests and found no significant differences between normal and GnRH-a-treated reproductive-aged women. The effects of short-term, that is, <6 weeks, administration of GnRH-a on pituitary TSH and PRL secretion, particularly during ovulation induction, remain unknown and deserve further study. Acknowledgments. We gratefully acknowledge the expert technical assistance of John O. Ritter, B.S., Stacy Tran, B.S., Y. Dong, B.S., and Amy Marshall, B.S., The University of Texas Southwestern Medical Center, Dallas, Texas. REFERENCES 1. Forti G. Clinical applications of GnRH analogs. J Endocrinol Invest 1988; 11: Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF Jr, et al. Use of a potent, long acting agonist of gonadotropin releasing hormone in the treatment of precocious puberty. Endocr Rev 1986;7: Word RA, Odom MJ, Byrd W, Carr BR. The effect of gonadotropin-releasing hormone agonists on growth hormone secretion in adult premenopausal women. Fertil Steril 1990; 54: Golan A, Bukovsky I, Weinraub Z, Ron-EI R, Herman A, Raziel A, et al. The effect of chronic gonadotropin-releasing hormone analogue (D-Trp6) treatment on elevated and normal serum prolactin levels. Fertil SteriI1989;51: Wilson EE, Little BB, Byrd W, McGee E, Carr BR. The effect of gonadotropin-releasing hormone agonists on adrenocorticotropin and cortisol secretion in adult premenopausal women. J Clin Endocrinol Metab 1993;76: Vol. 64, No.4, October 1995 Chantilis et ai. Effect of GnRH-a on TSH and PRL secretion 701
5 6. Cefcdars MI, Steingold KA, Lu JHL, Judd HJ, Meldrum DR. Pituitary function before, during, and after chronic gonadotropin-releasing hormone agonist therapy. Fertil Sterill992; 58: Venturini PL, Fasce V, Costantini S, Anserini P, Cucuccio S, de Cecco L. Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analogue: endocrine and clinical results. Fertil Steril 1990; 54: Sklar CA, Rothenberg S, Blumberg D, Oberfield SE, Levine LS, David R. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth hormone, insulin-like growth factor-i, and prolactin secretion. J Clin Endocrinol Metab 1991;73: Mettler L, Steinmiiller H, Schachner-Wiinschmann E. Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosis. Hum Reprod 1991;6: Fraser IS, Shearman RP, Jansen RPS, Sutherland PD. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol. Aust N Z J Obstet Gynaecol 1991;31:2: Yen SSC, Ehara Y, Siler TM. Augmentation of prolactin secretion by estrogen in hypogonadal women. J Clin Invest 1974; 53: Carr BR, Wilson JD. Disorders of the ovary and female reproductive tract. In: Isselbacher KJ, Braunwald E, Wilson JD, Marin JB, Fauci AS, Kasper DL, editors. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill, 1995: Chantilis et al. Effect of GnRH-a on TSH and PRL secretion Fertility and Sterility
Reproductive FSH. Analyte Information
Reproductive FSH Analyte Information 1 Follicle-stimulating hormone Introduction Follicle-stimulating hormone (FSH, also known as follitropin) is a glycoprotein hormone secreted by the anterior pituitary
More informationReproductive Health and Pituitary Disease
Reproductive Health and Pituitary Disease Janet F. McLaren, MD Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology jmclaren@uabmc.edu Objectives
More informationTreatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy*
Gynecology-endocrinology FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Printed on acid-free paper in U S. A. Treatment of hirsutism with a gonadotropin-releasing hormone agonist
More information2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:
2.0 Synopsis Abbott Laboratories Individual Study Table Referring to Part of Dossier: Name of Study Drug: Volume: Abbott-43818 (ABT-818) leuprolide acetate for depot suspension (Lupron Depot ) Name of
More informationOverview of Reproductive Endocrinology
Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,
More informationHypothyroidism and hyperprolactinemia showed positive correlation in women with primary and secondary infertility
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Valvekar U et al. Int J Reprod Contracept Obstet Gynecol. 2016 Jul;5(7):2079-2083 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationEndocrine Pharmacology
Endocrine Pharmacology 17-2-2013 DRUGS AFFECTING THE ENDOCRINE SYSTEM The endocrine system is the system of glands, each of which secretes a type of hormone directly into the bloodstream to regulate the
More informationThe reproductive system
The reproductive system THE OVARIAN CYCLE HORMONAL REGULATION OF OOGENSIS AND OVULATION hypothalamic-pituitary-ovary axis Overview of the structures of the endocrine system Principal functions of the
More informationThyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
Case Report Endocrinol Metab 2013;28:221-225 http://dx.doi.org/10.3803/enm.2013.28.3.221 pissn 2093-596X eissn 2093-5978 Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing
More informationThe effect of gonadotropin-releasing hormone agonists on growth hormone secretion in adult premenopausal women*
FERTILITY AND STERILITY Copyright 1990 The American Fertility Society Printed on acid-free paper in U.S.A. The effect of gonadotropin-releasing hormone agonists on growth hormone secretion in adult premenopausal
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationEndocrine part one. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy
Endocrine part one Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy HORMONES Hormones are chemicals released by a cell or a gland
More informationDaily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles
FRTILITY AND STRILITY Copyright 1983 The American Fertility Society Printed in U.8A. Daily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles Chung H. Wu, M.D. * F. Susan
More informationAssisted Reproductive Technology (ART) / Infertility / Synarel (nafarelin)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.03 Subject: Synarel Page: 1 of 5 Last Review Date: September 15, 2016 Synarel Description Assisted
More informationKey Words: Endometriosis, GnRH-a, goserelin, Zoladex, estrogen, sex-steroid add-back therapy,
FERTLTY AND STERLTY Copyright 1995 American Society for Reproductive Medicine Vol. 64, No. 5, November 1995 Printed on acid free paper in U. S. A. Comparison of the gonadotropin-releasing hormone agonist
More informationFrank Gonzalez, M.D.,* Lillie Chang, M.D., Theresa Horab, R.N.,* Frank Z. Stanczyk, Ph.D., Kent Crickard, M.D.,* and Rogerio A. Lobo, M.D.
FERTILITY AND STERILITY VOL. 71, NO. 3, MARCH 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Adrenal dynamic responses
More informationENDOCRINOLOGY COORDINATION OF PHYSIOLOGICAL PROCESSES:
ENDOCRINOLOGY COORDINATION OF PHYSIOLOGICAL PROCESSES: -In a living organism there must be coordination of number of physiological activities taking place simultaneously such as: movement, respiration,
More informationPharmacology of Hypothalamic Hormones
Pharmacology of Hypothalamic Hormones Pharmacology of Hypothalamic Hormones The neuroendocrine system, which is controlled by the pituitary and hypothalamus, coordinates body functions by transmitting
More informationEndocrine Glands. Endocrine glands
ENDOCRINOLOGY Endocrine Glands Endocrine glands Produce substances called hormones. Ductless glands, i.e., they release hormones directly into the bloodstream Hormones only act at their target tissue where
More informationOvarian response in three consecutive in vitro fertilization cycles
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in
More informationOccult hyperprolactinemia in infertile women
FRTILITY AND STRILITY Copyright e 1993 The American Fertility Society Printed on acidfree paper in U. S. A. Occult hyperprolactinemia in infertile women Kunio Asukai MD Tsuguo Uemura M.D Hiroshi Minaguchi
More informationFemale Reproductive System. Lesson 10
Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System
More informationCY Tse, AMK Chow, SCS Chan. Introduction
Effects of an extended-interval dosing regimen of triptorelin depot on the hormonal profile of patients with endometriosis: prospective observational study CY Tse, AMK Chow, SCS Chan Objective. To evaluate
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationHormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase
Patient Name: Patient DOB: Gender: Physician: Test Hormone Balance - Female Report SAMPLE Grote, Mary Jane Batch Number: B6437 2/16/1954 Accession Number: N52281 F Date Received: 2/3/2015 Any Lab Test
More informationEFFECT OF WEIGHT LOSS ON OVARIAN AND ADRENAL ANDROGEN SENSITIVITY. Department OB/GYN. EVMA Norfolk, Va Telephone: (804)
This study predates but predicts the use of glucophage, exercise and diet for the treatment of PCO. EFFECT OF WEIGHT LOSS ON OVARIAN AND ADRENAL ANDROGEN SENSITIVITY Principal Investigator: Hofheimer Hall
More informationKey words: polycystic ovary syndrome, hypothalmic-pituitary-ovarian axes
Clin Pediatr Endocrinol 1999; 8(2), 77-84 Copyright 1999 by The Japanese Society for Pediatric Endocrinology Clinical, Hormonal, and Radiological Studies at Baseline, During and After Long Term GnRH Analog
More informationFertility Diagnostics
Fertility Diagnostics Fertility hormones measured on PATHFAST For internal use only Diagnostics PATHFAST Chemiluminescence-immuno-analyzer 1 Content: page 1. Fertility hormones - general aspects 1.1 Reproductive
More informationLab Guide Endocrine Section Lab Guide
Lab Guide - 2019 Endocrine Section Lab Guide Estradiol Estradiol, Cerner Name: Estradiol Competitive test principle using a polyclonal antibody specifically directed against 17βestradiol in Roche Cobas
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationIdiopathic central precocious puberty associated with an enlarged pituitary gland
Idiopathic central precocious puberty associated with an enlarged pituitary gland Idiopathic central precocious puberty associated with an enlarged pituitary gland S Pathmanathan 1, Navoda Atapattu 2,
More informationHypothalamus & Pituitary Gland
Hypothalamus & Pituitary Gland Hypothalamus and Pituitary Gland The hypothalamus and pituitary gland form a unit that exerts control over the function of several endocrine glands (thyroid, adrenals, and
More informationPrescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care
Berkshire West Integrated Care System Representing Berkshire West Clinical Commisioning Group Royal Berkshire NHS Foundation Trust Berkshire Healthcare NHS Foundation Trust Berkshire West Primary Care
More informationThe Players. Liver Thyroid Adrenals Pancreas Reproductive System Pituitary Gut Bacteria
The Players Part I Quick Review Understanding some of the key systems and their relationship to hormones is the best place to start It will help with some of the hormone interconnections Key to understanding
More informationSHARED CARE PRESCRIBING GUIDELINE Triptorelin (Gonapeptyl Depot 3.75 mg TM, Decapeptyl SR mg TM ) for precocious puberty
WORKING IN PARTNERSHIP WITH SHARED CARE PRESCRIBING GUIDELINE Triptorelin (Gonapeptyl Depot 3.75 mg TM, Decapeptyl SR 11.25 mg TM ) for precocious puberty NHS Surrey s Medicines Management Committee classification:
More informationCASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?
CASE 41 A 19-year-old woman presents to her gynecologist with complaints of not having had a period for 6 months. She reports having normal periods since menarche at age 12. She denies sexual activity,
More informationOrgalutran 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1 1. NAME OF THE MEDICINAL PRODUCT 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe contains 0.25 mg of ganirelix (INN) in 0.5 mg aqueous solution.
More informationLab Exercise Endocrine System
Lab Exercise Endocrine System Name Date Materials: Human torso model Compound light microscope Prepared slides of the pituitary gland, pineal gland, thyroid gland, parathyroid glands, thymus gland, adrenal
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Infertility Injectables Table of Contents Coverage Policy... 1 General Background...16 Coding/Billing Information...20 References...20 Effective Date...
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationI. Endocrine System & Hormones Figure 1: Human Endocrine System
I. Endocrine System & Hormones Figure 1: Human Endocrine System Endocrine System: a) Endocrine glands are ductless since they lack specific vessels for the transport of hormones throughout the body. Instead,
More informationInfertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary
Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that
More informationLiving Control Mechanisms
Living Control Mechanisms Dr Kate Earp MBChB MRCP Specialty Registrar Chemical Pathology & Metabolic Medicine kate.earp@sth.nhs.uk 15/10/2015 Contents Aims & objectives Homeostasis Cell communication Introduction
More informationHuman Biochemistry. Hormones
Human Biochemistry Hormones THE ENDOCRINE SYSTEM THE ENDOCRINE SYSTEM THE ENDOCRINE SYSTEM The ENDOCRINE SYSTEM = the organ system that regulates internal environment conditions by secreting hormones into
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationEvaluation and Management of Pituitary Failure. Dr S. Ali Imran MBBS, FRCP (Edin), FRCPC Professor of Medicine Dalhousie University, Halifax, NS
Evaluation and Management of Pituitary Failure Dr S. Ali Imran MBBS, FRCP (Edin), FRCPC Professor of Medicine Dalhousie University, Halifax, NS Conflict of Interest None Objectives Diagnostic approach
More informationChanges of Hypophysio-Ovarian Endocrinological Function by Aging in Women
Tohoku J. exp. Med., 1977, 121, 231-238 Changes of Hypophysio-Ovarian Endocrinological Function by Aging in Women NOBUAKI FURUHASHI, MASAKUNI SUZUKI, TETSURO ABE, YOSHIHIRO YAMAY A and KATSUYUKI TAKAHASHI
More informationLIE ASSAY OF GONADOTROPIN in human blood is one of the most important
Changes in Human Serum FSH Levels During the Normal Menstrual Cycle MASAO IGARASHI, M.D., JUNJI KAMIOKA, M.D., YOICHI EHARA, M.D., and SEIICHI MATSUMOTO, M.D. LIE ASSAY OF GONADOTROPIN in human blood is
More informationwww.iffs-reproduction.org @IntFertilitySoc Int@FedFertilitySoc Conflict of interest none Outline Causes of ovulatory dysfunction Assessment of women with ovulatory dysfunction Management First line Second
More informationReproductive System (Hormone Function) Physiology Department Medical School, University of Sumatera Utara
Reproductive System (Hormone Function) Physiology Department Medical School, University of Sumatera Utara 1 Endocrine Control: Three Levels of Integration Hormones of the hypothalamic-anterior pituitary
More informationCase Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation
Polycystic Ovarian Syndrome: Treatment Goals and Options Marc Cornier, MD Division of Endocrinology, Metabolism and Diabetes Colorado Center for Health and Wellness University of Colorado School of Medicine
More informationA comparative study between agonist and antagonist protocol for ovarian stimulation in art cycles at a rural set up in South Gujarat
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nadkarni PK et al. Int J Reprod Contracept Obstet Gynecol. 2015 Jun;4(3):617-621 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationPROLACTIN-SECRETING PITUITARY MICROADENOMA: DETECTION AND EVALUATION*t
FERTILITY AND STERILITY Copyright 1978 The American Fertility Society Vol. 29, No.3, March 1978 PrinlRd in U.s.A. PROLACTIN-SECRETING PITUITARY MICROADENOMA: DETECTION AND EVALUATION*t R. HERBERT WIEBE,
More informationNOTES 11.5: ENDOCRINE SYSTEM. Pages
NOTES 11.5: ENDOCRINE SYSTEM Pages 1031-1042 ENDOCRINE SYSTEM Communication system that controls metabolism, growth, and development with hormones Maintains homeostasis Hormones: chemical messengers released
More informationStage 4 - Ovarian Cancer Symptoms
WELCOME Stage 4 - Ovarian Cancer Symptoms University of Baghdad College of Nursing Department of Basic Medical Sciences Overview of Anatomy and Physioloy II Second Year Students Asaad Ismail Ahmad,
More informationApproach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD
Approach to ovulation induction and superovulation in women with a history of infertility Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the
More informationlbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More informationHYPOTHALAMO PITUITARY GONADAL AXIS
HYPOTHALAMO PITUITARY GONADAL AXIS Physiology of the HPG axis Endogenous opioids and the HPG axis (exerciseinduced menstrual disturbances) Effects of the immune system on the HPG axis (cytokines: interleukins
More informationGrowth Hormone, Somatostatin, and Prolactin 1 & 2 Mohammed Y. Kalimi, Ph.D.
Growth Hormone, Somatostatin, and Prolactin 1 & 2 Mohammed Y. Kalimi, Ph.D. I. Growth Hormone (somatotropin): Growth hormone (GH) is a 191 amino acid single chain polypeptide (MW 22,000 daltons). Growth
More informationPrevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study
Prevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study Mousa Mohsen Ali* Wasan Ghazi* HayderAamerAbboud^ *Kerbala University, College of Medicine, Gynecology
More informationChapter 20. Endocrine System Chemical signals coordinate body functions Chemical signals coordinate body functions. !
26.1 Chemical signals coordinate body functions Chapter 20 Endocrine System! Hormones Chemical signals Secreted by endocrine glands Usually carried in the blood Cause specific changes in target cells Secretory
More informationEndocrine secretion cells secrete substances into the extracellular fluid
Animal Hormones Concept 30.1 Hormones Are Chemical Messengers Endocrine secretion cells secrete substances into the extracellular fluid Exocrine secretion cells secrete substances into a duct or a body
More informationSomatostatin Analog and Estrogen Treatment in a Tall Girl
Clin Pediatr Endocrinol 1995; 4 (2): 163-167 Copyright (C) 1995 by The Japanese Society for Pediatric Endocrinology Somatostatin Analog and Estrogen Treatment in a Tall Girl Toshiaki Tanaka, Mari Satoh,
More informationChapter 11. Endocrine System
Chapter 11 Endocrine System 1 Introduction A. The endocrine system is made up of the cells, tissues, and organs that secrete hormones into body fluids. B. Hormones diffuse into the bloodstream to act target
More informationEndocrine System. Chapter 20. Endocrine Glands and Hormones. The Endocrine System. Endocrine glands
Chapter 20 Endocrine System Endocrine Glands and Hormones The endocrine system consists of glands and tissues that secrete hormones Hormones are chemicals that affect other glands or tissues, many times
More informationProlactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234)
Prolactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234) Common presenting symptoms/clinical assessment: Pituitary adenomas are benign neoplasms of the pituitary gland.
More informationChapter 45-Hormones and the Endocrine System. Simple Hormone Pathways
Chapter 45-Hormones and the Endocrine System Simple Hormone s Low ph in duodenum Hormones are released from an endocrine, travel through the bloodstream, and interact with the receptor or a target to cause
More informationThe reproductive lifespan
The reproductive lifespan Reproductive potential Ovarian cycles Pregnancy Lactation Male Female Puberty Menopause Age Menstruation is an external indicator of ovarian events controlled by the hypothalamicpituitary
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More informationJournal of Medical Science & Technology
Journal of Medical Science & Technology Original article Open Access Prevalence of hyperprolactinaemia and hypothyroidism in primary and secondary infertility women Dr. Umakant Valvekar 1*, Dr. S.Viswanathan
More informationA Prospective Observational Study to Evaluate the Efficacy and Safety Profiles of Leuprorelin 3 Month Depot for the Treatment of Pelvic Endometriosis
SH SUEN & SCS CHAN A Prospective Observational Study to Evaluate the Efficacy and Safety Profiles of Leuprorelin 3 Month Depot for the Treatment of Pelvic Endometriosis Sik Hung SUEN MBChB, MRCOG Resident
More information1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.
1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH. 2. This causes the anterior pituitary to secrete small quantities of FSH and LH. 3. At this time, the follicles in the
More informationEndocrine system overview
Endocrine system overview Nature of the hormonal system -Major integrator of body function Classification of hormones Endocrine vs paracrine Nature of hormone-receptor systems Role of the hypothalamuspituitary
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationPrognostic value of day 3 estradiol on in vitro fertilization outcome*
FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization
More informationEndocrine System. Endocrine vs. Exocrine. Bio 250 Human Anatomy & Physiology
Endocrine System Bio 250 Human Anatomy & Physiology Endocrine vs. Exocrine Endocrine glands secrete their products called hormones into body fluids (the internal environment) Exocrine glands secrete their
More informationENDOCRINE SYSTEM. Endocrine
ENDOCRINE SYSTEM Endocrine Function Help regulate internal functions Use chemical messengers Recall: Endocrine vs. Exocrine glands Nervous System vs Endocrine System Target Specificity Lock n Key action
More informationLIVER PHYSIOLOGY AND DISEASE
0016-5085/78/7501-0066$02.00/0 GASTROENTEROLOGY 75:66-70, 1978 Copyright 1978 by the American Gastroenterological Association Vol. 75, No.1 Printed in U.s.A. LIVER PHYSIOLOGY AND DISEASE THYROTROPIN-RELEASING
More informationCATEGORY Endocrine System Review. Provide labels for the following diagram CHAPTER 13 BLM
CHAPTER 13 BLM 13.1.1 CATEGORY Endocrine System Review Provide labels for the following diagram. 1. 6. 2. 7. 3. 8. 4. 9. 5. 10. CHAPTER 13 BLM 13.1.2 OVERHEAD Glands and Their Secretions Endocrine gland
More informationCh 8: Endocrine Physiology
Ch 8: Endocrine Physiology Objectives 1. Review endocrine glands of body. 2. Understand how hypothalamus controls endocrine system & sympathetic epinephrine response. 3. Learn anterior pituitary hormones
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationPITUITARY: JUST THE BASICS PART 2 THE PATIENT
PITUITARY: JUST THE BASICS PART 2 THE PATIENT DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and
More informationNeuroendocrine Disorders in Women
Neuroendocrine Disorders in Women Ursula B. Kaiser, M.D. Chief, Division of Endocrinology, Diabetes and Hypertension Brigham and Women s Hospital Professor of Medicine, Harvard Medical School Case Presentation
More informationme LUTEINIZED UNRUPTURED FOLLICLE SYNDROME AND ENDOMETRIOSIS
FERTILITY AND STERILITY Copyright c 980 The American Fertility Society Vol. 33,, JanuaEY 980 Printed in U.S.A. me LUTEINIZED UNRUPTURED FOLLICLE SYNDROME AND ENDOMETRIOSIS W. PAULDMOWSKI, M.D.,.PH.D.*
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationclinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome
& clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome Zulfo Godinjak¹*, Ranka Javorić² 1 Gynecology and Obstetrics
More informationTest Briefing on Hormonal Disorders and Infertility
Test Briefing on Hormonal Disorders and Infertility Test Briefing on Hormonal Disorders Common Tests FSH LH Progesterone Estradiol Prolactin Testosterone AFP AMH PCOS Panel FSH (Follicle Stimulating Hormone)
More informationNitasha Garg 1 Harkiran Kaur Khaira. About the Author
https://doi.org/10.1007/s13224-017-1082-4 ORIGINAL ARTICLE A Comparative Study on Quantitative Assessment of Blood Flow and Vascularization in Polycystic Ovary Syndrome Patients and Normal Women Using
More information2017 United HealthCare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017
More informationA single sample GnRHa stimulation test in the diagnosis of precocious puberty
Yazdani et al. International Journal of Pediatric Endocrinology 212, 212:23 RESEARCH Open Access A single sample GnRHa stimulation test in the diagnosis of precocious puberty Parvin Yazdani 1*, Yuezhen
More informationInfertility: A Generalist s Perspective
Infertility: A Generalist s Perspective Learning Objectives Fertility and Lifestyle: Patient education Describe the basic infertility workup Basic treatment strategies unexplained Heather Huddleston, MD
More informationMICROWELL ELISA LUTEINIZING HORMONE (LH) ENZYMEIMMUNOASSAY TEST KIT LH ELISA. Cat # 4225Z
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationEndocrine system. General principle of endocrinology. Mode of hormone delivery to target. Mode of hormone delivery to target
Endocrine system General principle of endocrinology Co-ordinating system to regulate and integrate function of different cells - Nervous system -Endocrine system Neuro-endocrine system Hormone Molecules
More informationDevelopment Team. Department of Zoology, University of Delhi. Department of Zoology, University of Delhi
Paper Module : 06 : 17 Development Team Principal Investigator : Prof. Neeta Sehgal Department of Zoology, University of Delhi Co-Principal Investigator : Prof. D.K. Singh Department of Zoology, University
More informationTest Results SB Samples Arrived: 01/15/2014 Samples Collected: Saliva: 01/11/14 07:14 Date Closed: 01/18/2014
Test Results 8605 SW Creekside Place Beaverton, OR 97008 Phone: 503-466-2445 Fax: 503-466-1636 info@zrtlab.com www.zrtlab.com 2014 01 15 001 SB Samples Arrived: 01/15/2014 Samples Collected: Saliva: 01/11/14
More informationREPRODUCTION & GENETICS. Hormones
REPRODUCTION & GENETICS Hormones http://www.youtube.com/watch?v=np0wfu_mgzo Objectives 2 Define what hormones are; Compare and contrast the male and female hormones; Explain what each hormone in the mail
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More informationN. Shirazian, MD. Endocrinologist
N. Shirazian, MD Internist, Endocrinologist Inside the ovary Day 15-28: empty pyfollicle turns into corpus luteum (yellow body) Immature eggs Day 1-13: 13: egg developing inside the growing follicle Day
More informationOBJECTIVES. Rebecca McEachern, MD. Puberty: Too early, Too Late or Just Right? Special Acknowledgements. Maryann Johnson M.Ed.
1 Puberty: Too early, Too Late or Just Right? Maryann Johnson M.Ed., BSN, RN Special Acknowledgements Rebecca McEachern, MD OBJECTIVES Illustrate basic endocrine system and hormonal pathways Define the
More informationPubertal evaluation of adolescent boys with -thalassemia major and delayed puberty
Pubertal evaluation of adolescent boys with -thalassemia major and delayed puberty Hala Saleh Al-Rimawi, M.D., F.R.C.P., a Mohammad Fayez Jallad, M.D., M.R.C.O.G., b Zouhair Odeh Amarin, M.D., F.R.C.O.G.,
More information